1. Home
  2. STE vs DGX Comparison

STE vs DGX Comparison

Compare STE & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STERIS plc (Ireland)

STE

STERIS plc (Ireland)

HOLD

Current Price

$263.47

Market Cap

25.9B

Sector

Health Care

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$182.89

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STE
DGX
Founded
1985
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.9B
20.5B
IPO Year
1992
1996

Fundamental Metrics

Financial Performance
Metric
STE
DGX
Price
$263.47
$182.89
Analyst Decision
Buy
Buy
Analyst Count
9
15
Target Price
$268.25
$194.07
AVG Volume (30 Days)
674.3K
1.2M
Earning Date
11-05-2025
10-21-2025
Dividend Yield
0.96%
1.75%
EPS Growth
59.39
14.49
EPS
6.97
8.51
Revenue
$5,702,415,000.00
$10,850,000,000.00
Revenue This Year
$9.24
$12.37
Revenue Next Year
$6.30
$3.52
P/E Ratio
$37.72
$21.44
Revenue Growth
7.08
13.74
52 Week Low
$200.98
$148.70
52 Week High
$268.60
$197.55

Technical Indicators

Market Signals
Indicator
STE
DGX
Relative Strength Index (RSI) 59.06 44.87
Support Level $256.68 $184.18
Resistance Level $268.60 $185.12
Average True Range (ATR) 4.64 3.22
MACD -0.69 -0.78
Stochastic Oscillator 65.59 3.85

Price Performance

Historical Comparison
STE
DGX

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: